IP10 has been shown to play a key role as an inflammatory mediator in several diseases including viral infections (e.g. hepatitis C), diabetes, cardiovascular disease, nonalcoholic fatty liver disease, and neurodegenerative diseases [32–34]. Here, CXCL10 is linked to metabolic dysfunction-associated steatotic liver disease.